Genenta Science Stock (NASDAQ: GNTA) stock price, news, charts, stock research, profile.
Open | $3.473 |
Close | $3.473 |
Volume / Avg. | 317.000 / 5.997K |
Day Range | 3.473 - 3.473 |
52 Wk Range | 2.200 - 6.810 |
Market Cap | $42.810M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 0.03% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Genenta Science (NASDAQ: GNTA) through any online brokerage.
Other companies in Genenta Science’s space includes: Kezar Life Sciences (NASDAQ:KZR), CARISMA Therapeutics (NASDAQ:CARM), Intensity Therapeutics (NASDAQ:INTS), Eagle Pharmaceuticals (NASDAQ:EGRX) and Aligos Therapeutics (NASDAQ:ALGS).
The latest price target for Genenta Science (NASDAQ: GNTA) was reported by Roth MKM on Thursday, June 29, 2023. The analyst firm set a price target for 15.00 expecting GNTA to rise to within 12 months (a possible 538.30% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Genenta Science (NASDAQ: GNTA) is $2.35 last updated April 26, 2024 at 5:02 PM EDT.
There are no upcoming dividends for Genenta Science.
Genenta Science does not have any upcoming earnings scheduled.
There is no upcoming split for Genenta Science.
Genenta Science is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.